EXTH-23. MULTIVALENT TARGETED CYTOLYTIC AGENTS FOR GLIOBLASTOMA TREATMENT

Glioblastoma (GBM) complexity and heterogeneity requires treatment that addresses those pathobiological features. We have been developing selective cytotoxic agents able to target at the same time several GBM-associated factors. The chosen targets are responsible for the disease progression and/or r...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Sharma, Puja, Herpai, Denise, Roberts, Callie, Fokt, Izabela, Priebe, Waldemar, Tatter, Stephen, Rossmeisl, John, Debinski, Waldemar
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Preclinical Experimental Therapeutics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651650/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.377
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items